{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:33:51Z","timestamp":1788543231038,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek Vlaanderen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clnesp.2024.10.161","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T16:52:01Z","timestamp":1730479921000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Real-world experience with glucagon-like peptide 2 analogues in patients with short bowel syndrome and chronic intestinal failure: Results from an international survey in expert intestinal failure centers"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-0903","authenticated-orcid":false,"given":"Tim","family":"Vanuytsel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narisorn","family":"Lakananurak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Greif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Catron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Herlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Moccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Kumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mercer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berner-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Gramlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnesp.2024.10.161_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clnu.2016.01.020","article-title":"ESPEN guidelines on chronic intestinal failure in adults","volume":"35","author":"Pironi","year":"2016","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2024.10.161_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2024.10.161_bib3","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/jpen.2426","article-title":"Characteristics of chronic intestinal failure in the USA based on analysis of claims data","volume":"46","author":"Mundi","year":"2022","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2024.10.161_bib4","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ncp.10926","article-title":"Characteristics of adult intestinal failure centers: an international multicenter survey","volume":"38","author":"Lakananurak","year":"2023","journal-title":"Nutr Clin Pract"},{"issue":"1 Suppl","key":"10.1016\/j.clnesp.2024.10.161_bib5","first-page":"60S","article-title":"Short bowel syndrome in adults: the need for an interdisciplinary approach and coordinated care","volume":"38","author":"Matarese","year":"2014","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"10","key":"10.1016\/j.clnesp.2024.10.161_bib6","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.clnu.2023.07.019","article-title":"ESPEN guideline on chronic intestinal failure in adults - update 2023","volume":"42","author":"Pironi","year":"2023","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2024.10.161_bib7","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.clnu.2012.08.007","article-title":"Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome","volume":"32","author":"Amiot","year":"2013","journal-title":"Clin Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.clnesp.2024.10.161_bib8","first-page":"S76","article-title":"Treatment of short bowel syndrome: breaking the therapeutic ceiling?","volume":"38","author":"Wauters","year":"2023","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"10.1016\/j.clnesp.2024.10.161_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030628","article-title":"The role of a colon-in-continuity in short bowel syndrome","volume":"15","author":"Verbiest","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2024.10.161_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/MED.0000000000000710","article-title":"Enterohormone therapy for short bowel syndrome","volume":"29","author":"Verbiest","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"3","key":"10.1016\/j.clnesp.2024.10.161_bib11","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.47.3.370","article-title":"Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon","volume":"47","author":"Jeppesen","year":"2000","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.clnesp.2024.10.161_bib12","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/gut.45.4.559","article-title":"Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure","volume":"45","author":"Jeppesen","year":"1999","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.clnesp.2024.10.161_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/gut.39.2.267","article-title":"Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying","volume":"39","author":"Nightingale","year":"1996","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clnesp.2024.10.161_bib14","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clnesp.2024.10.161_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/01.tp.0000945720.64507.04","article-title":"Glepaglutide induces meaningful clinical improvement in patients with short bowel syndrome chronic intestinal failure: results of a phase 3 trial","volume":"107","author":"Jeppesen","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.clnesp.2024.10.161_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clnesp.2022.12.029","article-title":"A\u00a0multidisciplinary team evaluation of management guidelines for adult short bowel syndrome","volume":"54","author":"Wall","year":"2023","journal-title":"Clin Nutr ESPEN."},{"key":"10.1016\/j.clnesp.2024.10.161_bib17","first-page":"41","article-title":"Characteristics of adult intestinal failure centers: an international multicenter survey","volume":"54","author":"Lakananurak","year":"2023","journal-title":"Nutr Clin Pract"},{"issue":"12","key":"10.1016\/j.clnesp.2024.10.161_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu15122763","article-title":"Real-world management of high stool output in patients with short bowel syndrome: an international multicenter survey","volume":"15","author":"Lakananurak","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2024.10.161_bib19","series-title":"Efficacy and safety evaluation of glepaglutide in treatment of SBS (EASE SBS 1)","year":"2018"},{"issue":"10","key":"10.1016\/j.clnesp.2024.10.161_bib20","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1007\/s10620-019-05779-0","article-title":"The long road to the development of effective therapies for the short gut syndrome: a personal perspective","volume":"64","author":"Jeppesen","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clnesp.2024.10.161_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clnesp.2023.01.017","article-title":"Survey of healthcare professionals' experiences of care delivery in patients with chronic intestinal failure: ATLAS of Variance","volume":"54","author":"Geransar","year":"2023","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"10.1016\/j.clnesp.2024.10.161_bib22","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1016\/j.clnu.2021.02.011","article-title":"Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: a systematic analysis of a single centre cohort","volume":"40","author":"Pironi","year":"2021","journal-title":"Clin Nutr"},{"issue":"11","key":"10.1016\/j.clnesp.2024.10.161_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu15112448","article-title":"Post-marketing use of teduglutide in a large cohort of adults with short bowel syndrome-associated chronic intestinal failure: evolution and outcomes","volume":"15","author":"de Dreuille","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2024.10.161_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gtc.2007.01.007","article-title":"Growth factors in short-bowel syndrome patients","volume":"36","author":"Jeppesen","year":"2007","journal-title":"Gastroenterol Clin N Am"},{"key":"10.1016\/j.clnesp.2024.10.161_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clnesp.2021.03.011","article-title":"Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support","volume":"43","author":"Chen","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnesp.2024.10.161_bib26","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818793343","article-title":"GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting","volume":"11","author":"Schoeler","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"issue":"9","key":"10.1016\/j.clnesp.2024.10.161_bib27","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2024.10.161_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jpen.1838","article-title":"Long-term outcomes with teduglutide from a single center","volume":"45","author":"Puello","year":"2021","journal-title":"JPEN - J Parenter Enter Nutr"},{"key":"10.1016\/j.clnesp.2024.10.161_bib29","article-title":"Efficacy and safety of apraglutide once-weekly in patients with short bowel syndrome and intestinal failure (SBS-IF): results from the STARS study - a global phase 3 double-blind, randomized, placebo-controlled trial","volume":"166","author":"Joly","year":"2023","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clnesp.2024.10.161_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clnu.2013.03.016","article-title":"Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study","volume":"32","author":"Jeppesen","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2024.10.161_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820905766","article-title":"Teduglutide for the treatment of adults with intestinal failure associated with short bowel syndrome: pooled safety data from four clinical trials","volume":"13","author":"Pape","year":"2020","journal-title":"Therap Adv Gastroenterol"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724014992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457724014992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T12:44:59Z","timestamp":1733143499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457724014992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":31,"alternative-id":["S2405457724014992"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.10.161","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world experience with glucagon-like peptide 2 analogues in patients with short bowel syndrome and chronic intestinal failure: Results from an international survey in expert intestinal failure centers","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2024.10.161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.","name":"copyright","label":"Copyright"}]}}